Aller au contenu

Antimicrobial Stewardship Outcomes in CHU Hospitals

Antimicrobial stewardship outcomes in academic hospital centers reflect the interplay between clinical decision-making, microbiological diagnostic capacity, and institutional policy enforcement. A critical divergence persists between empirical prescribing habits and targeted microbiological therapies across tertiary inpatient departments. Systematic evaluation of stewardship programs provides measurable criteria to optimize therapeutic efficacy and mitigate pathogen resistance across diverse clinical settings.

Objectif

How do antimicrobial stewardship initiatives alter prescribing patterns, diagnostic integration, and clinical outcomes across tertiary university teaching hospitals?

Méthodologie

Comparative analysis of standardized point prevalence surveys, digital drug consumption audits, and secondary literature across university hospital settings.

Nouveauté scientifique

Characterizes the structural disconnect between microbial resistance patterns and empirical prescribing in academic hospitals across diverse resource settings.

Aperçu du document

Ceci est un aperçu succinct. La version complète comprend un texte étendu pour toutes les sections, une conclusion et une bibliographie formatée.

PhD Dissertation

Degree:
Antimicrobial Stewardship Outcomes in CHU Hospitals

Author:

Group

First M. Last

Advisor:

Dr. First Last

City, 2026

Contents

Introduction
Chapter 1. Conceptual Framework of Antimicrobial Stewardship in Academic Medical Centers
1.1 Clinical and Institutional Drivers of Antimicrobial Resistance
1.2 Structural Organization of Centre Hospitalier Universitaire Facilities
1.3 The WHO AWaRe Classification and Global Prescribing Frameworks
1.4 Determinants of Guideline Adherence in Teaching Environments
Chapter 2. Methodological Standards for Evaluating Stewardship Outcomes
2.1 Comparative Design of Standardized Point Prevalence Surveys
2.2 Evaluation Criteria for Multi-Center Longitudinal Data Sets
2.3 Metrics for Categorizing Empiric versus Targeted Therapy
2.4 Methodological Boundaries in Cross-Regional Surveillance
Chapter 3. Analytical Evaluation of Antibiotic Prescribing Patterns
3.1 Distribution of Broad-Spectrum beta-Lactams in Inpatient Wards
3.2 Utilization Trends of Watch and Access Antimicrobial Classes
3.3 Microbiological Diagnostic Coverage and Susceptibility Testing Rates
3.4 Multi-Agent Regimens and Treatment Density in Acute Inpatient Units
Chapter 4. Institutional Discrepancies and Technological Optimization
4.1 Decoupling of Resistance Rates and Consumption Volumes
4.2 Decision-Support Software and Regional Surveillance Systems
4.3 Resource Stratification in High-Income and Developing Healthcare Settings
4.4 Nosocomial Infection Dynamics Across Acute Care Infrastructure
Chapter 5. Critical Synthesis of Stewardship Interventions and Clinical Policies
5.1 Therapeutic Optimization in Surgical and Pediatric Populations
5.2 Systemic Constraints on Diagnostic Pathways in Academic Hospitals
5.3 Regional Variations in Antimicrobial Control Programs
5.4 Translation of Stewardship Policies into Departmental Practice
Chapter 6. Strategic Guidelines for Sustainable Stewardship Programs
6.1 Frameworks for Integrating Point-of-Care Diagnostic Testing
6.2 Interdisciplinary Governance in University Hospital Centers
6.3 Standardizing Quality Indicators across Clinical Directorates
Conclusion
Bibliography

Introduction

Antimicrobial resistance represents one of the most critical threats to modern clinical medicine, undermining routine therapeutic regimens and complex surgical procedures across acute tertiary care environments. In university teaching hospitals (Centre Hospitalier Universitaire, CHU), the intersection of specialized clinical services, high patient acuity, and extensive empirical antimicrobial prescribing creates an environment that accelerates resistance selection [1]. Establishing robust antimicrobial stewardship programs within these academic institutions is essential to optimize therapeutic outcomes and curb the emergence of multi-drug resistant pathogens.

A central operational problem in CHU facilities concerns the persistent reliance on broad-spectrum therapies in the absence of systematic microbiological verification. Evidence indicates that empirical antibiotic selection remains predominant across inpatient services, with substantial proportions of patients receiving combination regimens without pathogen confirmation [1]. Furthermore, regional surveillance demonstrates that local resistance trends often fail to correlate predictably with prescribing intensity, highlighting complex institutional, diagnostic, and behavioral determinants that govern therapeutic choices [2, 3].

The fundamental goal of this investigation is to examine the measurable clinical, microbiological, and institutional outcomes of antimicrobial stewardship initiatives implemented across university hospital networks. Using standardized point prevalence survey protocols, cross-sectional consumption analyses, and surveillance metrics, this dissertation evaluates the structural drivers of antibiotic utilization and diagnostic integration [1, 2]. By contrasting high-density resource settings with developing tertiary centers, the research identifies systemic determinants governing prescribing quality and adherence to evidence-based therapeutic guidelines.

The scientific relevance of this work resides in establishing comparative benchmarks for antimicrobial stewardship efficacy within academic medical centers facing diverse infrastructural realities. Synthesizing international classification frameworks, digital surveillance tools, and clinical practice variations provides essential theoretical and practical evidence for health policymakers and clinical leaders [1, 2, 3]. Ultimately, this research offers a comprehensive evaluation framework designed to enhance diagnostic stewardship, optimize drug selection, and secure long-term therapeutic efficacy across university hospital ecosystems.

2.1 Comparative Design of Standardized Point Prevalence Surveys

Standardizing surveillance protocols across tertiary university hospital centers requires robust methodological criteria that differentiate empirical therapy from microbiologically guided regimens. When evaluating clinical prescription pathways, cross-sectional point prevalence survey methodologies established by the World Health Organization provide a validated framework to assess inpatient drug distribution, multi-agent therapeutic combinations, and institutional adherence to the AWaRe categorization schema [1]. Applying structured point prevalence auditing enables clinical investigators to quantify systemic diagnostic gaps in inpatient management, systematically identifying high baseline levels of empirical prescribing alongside underutilized microbiological examination and susceptibility testing across acute care wards [1]. Such standardized survey designs capture granular ward-level prescribing habits and diagnostic delays across diverse inpatient directorates, including pediatric and surgical services where targeted regimens remain severely constrained [1]. Furthermore, point prevalence audits offer structured benchmarks for evaluating the proportion of patients receiving multi-agent therapies or broad-spectrum beta-lactams [1]. To overcome the intrinsic temporal limitations of single-day cross-sectional audits, regional surveillance frameworks and specialized decision-support software facilitate longitudinal tracking across multiple academic healthcare facilities, integrating antibiotic consumption metrics with institutional resistance patterns [2]. Combining standardized point prevalence data with multi-center longitudinal digital monitoring tools establishes a rigorous methodological foundation to measure stewardship guideline implementation, calibrate institutional diagnostic workflows, and evaluate policy interventions aimed at curbing unguided broad-spectrum antimicrobial use [1] [2]. Consequently, this integrated methodological approach bridges immediate departmental prescribing practices with wider multi-center epidemiological surveillance priorities, establishing reliable and reproducible quality indicators across university hospital networks.

References

  1. Antibiotic use at the Centre Hospitalier Universitaire de Zone d'Abomey Calavi/Sô-Ava (CHUZ/AS) in Benin: a point prevalence survey
    Morelle Sèssiwèdé Gnimavo, Bawa Boya, Steward Mudenda et al.
    Lien DOI
  2. A new software to help optimize regional antimicrobial stewardship policy? Results from a two year-survey of antibiotic consumption and antimicrobial resistance in five hospitals in South-Eastern France
    Florence Lieutier-Colas
    Lien DOI
  3. Antimicrobial resistance rates do not drive antibiotic consumption in Europe
    Evelina Tacconelli
    Lien DOI
  4. Syndrome de Terson : Une observation clinique au CHU IOTA (Centre Hospitalier Universitaire Institut d'Ophtalmologie Tropicale d'Afrique)
    RD Sangaré, N Guirou, M Sissoko et al.
  5. Facteurs associés à la mortalité des enfants de plus de cinq ans hospitalisés pour paludisme grave au centre hospitalier universitaire régional de Ouahigouya au Burkina Faso
    AS Ouermi, M Barro, B Sanogo et al.
  6. CLABSI rates variation prior to and during the COVID-19 pandemic in two hospitals in Montreal, Canada
    Yinan Li, Virginie Boulanger, Patrice Savard et al.
  7. Acute Lymphoblastic Leukemia: About a Case Observed at the Renaissance University Hospital in N'Djamena.
    Hassan Adam Annour, Ildjima Ousmane Kadallah, Mahamat Ali Bolti et al.
  8. Pratique de la thrombolyse dans l’AVC ischémique aigu en milieu hospitalier français : état des lieux et perspectives pour l’Afrique subsaharienne
    S Sanguisso, AA Dabilgou, AA Baby et al.

Bibliographie

Sources VérifiéesNormes de FormatageHaute UnicitéModèles Pro
🔥 25% OFF

Thèse

NF ISO 690

24 €31 €
  • 120+ pages
  • Haute originalité
  • Exporter vers Word
  • Formatage correct
  • Aperçu public
    L'aperçu d'un autre auteur ne peut pas être rendu privé. Votre travail sera privé et totalement unique.
  • Bibliographie (100+, NF ISO 690)
    +1 €
  • Ajouter des sources alternatives (Actualités, .gov, .edu)

Thèse

NF ISO 690